Rationally designed drug combination screen in more physiologically relevant in vitro organoid models : can we improve personalized therapy for pancreatic cancer?
Source
Antwerp, University of Antwerp, Faculty of Medicine and Health Sciences, 2026,186 p.
Development and validation of the Normalized Organoid Growth Rate (NOGR) metric in brightfield imaging-based assays
Source
Communications Biology - ISSN 2399-3642-7:1 (2024) p. 1-11
"Keep on ROCKIn" : repurposed ROCK inhibitors to boost corneal endothelial regeneration
Source
Biomedicine and pharmacotherapy - ISSN 0753-3322-174 (2024) p. 1-12
Auranofin repurposing for lung and pancreatic cancer : low CA12 expression as a marker of sensitivity in patient-derived organoids, with potentiated efficacy by AKT inhibition
Source
Journal of Experimental and Clinical Cancer Research - ISSN 1756-9966-43:1 (2024) p. 1-15
IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts
Source
Journal of hematology and oncology - ISSN 1756-8722-17:1 (2024) p. 1-19